| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | 1 | — | — | — |
| Sell | — | — | 1 | 1 | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.42 |
—
—
—
—
|
| 2025 | 1.56 |
—
—
—
—
|
| 2024 | 1.48 |
—
—
—
—
|
| 2023 | 1.48 |
—
—
—
—
|
| 2022 | 1.48 |
—
—
—
—
|
| 2021 | 1.48 |
—
—
—
—
|
| 2020 | 1.40 |
—
—
—
—
|
| 2019 | 1.40 |
—
—
—
—
|
| 2018 | 1.40 |
—
—
—
—
|
| 2017 | 1.40 |
—
—
—
—
|
| 2016 | 1.29 |
—
—
—
—
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 189.00 | 108.00 | 132.00 | 394.00 |
| Receivables | 529.00 | 630.00 | 583.00 | 578.00 |
| Inventory | 1,291.00 | 1,386.00 | 1,424.00 | 1,612.00 |
| Other | 52.00 | 66.00 | 93.00 | 136.00 |
| 2,061.00 | 2,190.00 | 2,232.00 | 2,720.00 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 1,306.00 | 1,311.00 | 1,332.00 | 1,377.00 |
| ST’ Debt | 261.00 | — | — | — |
| Other | 635.00 | — | — | — |
| 2,222.00 | 3,576.00 | 2,906.00 | 3,336.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 2,677.00 | 2,564.00 | 2,366.00 | 2,137.00 |
9,744.00
|
| ’25 | 2,772.00 | 2,685.00 | 2,475.00 | 2,321.00 |
10,253.00
|
| ’24 | 2,518.00 | 2,456.00 | 2,369.00 | 2,293.00 |
9,636.00
|
| ’23 | 2,575.00 | 2,485.00 | 2,229.00 | 2,068.00 |
9,357.00
|
| ’22 | 2,236.00 | 2,209.00 | 2,130.00 | 1,987.00 |
8,562.00
|
| ’21 | 2,340.00 | 2,279.00 | 1,984.00 | 1,873.00 |
8,476.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 224.00 | 516.00 | 99.00 | 200.00 |
1,039.00
|
| ’25 | 225.00 | 512.00 | 135.00 | 259.00 |
1,131.00
|
| ’24 | 174.00 | 510.00 | 213.00 | 288.00 |
1,185.00
|
| ’23 | 227.00 | 505.00 | 186.00 | 225.00 |
1,143.00
|
| ’22 | 288.00 | 478.00 | 335.00 | 80.00 |
1,181.00
|
| ’21 | 180.00 | 431.00 | 270.00 | 154.00 |
1,035.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 97.00 | 416.00 | 29.00 | 189.00 |
731.00
|
| ’25 | 115.00 | 411.00 | 50.00 | 129.00 |
705.00
|
| ’24 | 31.00 | 390.00 | 100.00 | 147.00 |
668.00
|
| ’23 | 150.00 | 427.00 | 84.00 | 112.00 |
773.00
|
| ’22 | 219.00 | 418.00 | 285.00 | 17.00 |
939.00
|
| ’21 | 106.00 | 373.00 | 212.00 | 69.00 |
760.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 0.65 | 0.48 | 0.41 | (0.23) |
1.31
|
| ’25 | 0.72 | 0.58 | 0.22 | 0.48 |
2.01
|
| ’24 | 0.78 | 0.68 | 0.44 | (0.01) |
1.89
|
| ’23 | 0.99 | 0.77 | 0.53 | 0.57 |
2.85
|
| ’22 | 0.86 | 0.70 | 0.62 | 0.32 |
2.51
|
| ’21 | 1.02 | 0.80 | 0.52 | 0.95 |
3.29
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 41.73 | 37.94 | 40.26 | 27.64 | 19.56 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 57.78 | 57.24 | 52.81 | 43.85 | 29.99 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,700 | 14,500 | 14,400 | 13,700 | — | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.58 | 0.65 | 0.67 | 0.75 | 0.00 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,562.00 | 9,357.00 | 9,636.00 | 10,253.00 | 9,744.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.68% | 31.17% | 30.83% | 30.42% | 28.14% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 975.00 | 1,128.00 | 757.00 | 796.00 | 529.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.39% | 12.06% | 7.86% | 7.76% | 5.43% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 757.00 | 858.00 | 567.00 | 602.00 | 405.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 337.00 | 387.00 | 428.00 | 434.00 | 416.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.45 | 31.29 | 32.34 | 34.41 | 32.70 | ‡‡‡ | ‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.51 | 2.87 | 1.90 | 2.02 | 1.34 | ‡‡‡‡‡ | ‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.92 | 3.82 | 3.98 | 3.80 | 3.49 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.80) | (1.24) | (1.73) | (1.43) | (1.03) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.12 | 2.59 | 2.24 | 2.37 | 2.45 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.07 | 12.25 | 12.74 | 13.10 | 12.93 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 301.00 | 299.00 | 298.00 | 298.00 | 298.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.83 | 15.91 | 24.53 | 15.80 | 16.40 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.74 | 1.46 | 1.45 | 0.93 | 0.67 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.48 | 3.74 | 3.68 | 2.44 | 1.70 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.30 | 1.95 | 2.06 | 1.54 | 1.29 | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.97 | 23.64 | 29.78 | 22.34 | 17.23 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,181.00 | 1,143.00 | 1,185.00 | 1,131.00 | 1,039.00 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (242.00) | (370.00) | (517.00) | (426.00) | (308.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 939.00 | 773.00 | 668.00 | 705.00 | 731.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (923.00) | (161.00) | (1,386.00) | (674.00) | (616.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,872.00 | 4,759.00 | 5,761.00 | 6,095.00 | 6,160.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,763.00 | 4,570.00 | 5,653.00 | 5,963.00 | 5,766.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,333.00 | 3,663.00 | 3,796.00 | 3,904.00 | 3,852.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.41% | 7.16% | 4.15% | 4.00% | 2.58% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.98% | 9.96% | 6.61% | 7.12% | 5.54% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.34% | 24.53% | 15.20% | 15.64% | 10.16% | — | — | — |
ROE
|
Campbell Soup Company (CPB) has demonstrated resilience in a challenging consumer packaged goods landscape, pivoting from declining soup sales to high-margin snacks through the pivotal 2018 $6.1 billion Snyder’s-Lance acquisition. This move drove revenue from $7.96 billion in 2016 to $9.64 billion in 2024 at a 2.8% CAGR, with projections for modest growth to $10.2 billion by 2028 amid operational efficiencies—revenue per employee up 39% and headcount slashed 37%. Echoing post-merger struggles at peers like Kraft Heinz, CPB has faced margin compression from inflation and supply disruptions, with gross margins eroding to 30.8% and EBT margins to 7.9%, yet cash flow remains robust at $1.1-1.4 billion annually.
Balance sheet repairs post-acquisition are notable: debt halved to $4.76 billion by 2023 before a modest uptick, while equity doubled to $3.80 billion, boosting book value per share 245%. Stock performance has lagged revenue growth, with PS ratios compressing to 1.45x and forward PE eyed at 10.5x by 2028 on 48% EPS upside to $2.81, trading at levels reminiscent of Conagra’s undervalued reset. Insider selling without buys adds caution, but ROE above 15% and ROIC trends signal capital efficiency.
For patient investors, CPB warrants a hold, with 20-30% EPS growth potential through snack dominance and CEO Clouse’s transformation mirroring Unilever’s playbook—though risks like margin erosion and competition loom. Full analysis delves into projections, historical parallels, and entry tactics for the steadfast.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.